Back to Search Start Over

A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations.

Authors :
Hu, Lidan
Sun, Jingmiao
Wang, Yan
Tan, Danny
Cao, Zhongkai
Gao, Langping
Guan, Yuelin
Jia, Xiuwei
Mao, Jianhua
Source :
Vaccines; Jun2023, Vol. 11 Issue 6, p1045, 18p
Publication Year :
2023

Abstract

The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and vaccination is critical for preventing further spread or resurgence of the outbreak. Inactivated vaccines made from whole inactivated SARS-CoV-2 virus particles generated in Vero cells are currently the most widely used COVID-19 vaccines, with China being the largest producer of inactivated vaccines. As a result, the focus of this review is on inactivated vaccines, with a multidimensional analysis of the development process, platforms, safety, and efficacy in special populations. Overall, inactivated vaccines are a safe option, and we hope that the review will serve as a foundation for further development of COVID-19 vaccines, thus strengthening the defense against the pandemic caused by SARS-CoV-2. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
2076393X
Volume :
11
Issue :
6
Database :
Complementary Index
Journal :
Vaccines
Publication Type :
Academic Journal
Accession number :
164688204
Full Text :
https://doi.org/10.3390/vaccines11061045